Moreover, the simulation of the sepsis by intraperitoneal LPS injection perturbs sphingosine metabolism in brain microvessels with a net decrease of S1PR1 levels [41], thus linking alterations of sphingolipid metabolism to the pathogenesis of septic encephalopathy. Here, S1PR1 is linked to Sepsis.